Botanical species · safety record

Asparagus cochinchinensis

The EFSA Compendium of Botanicals holds 14 constituent measurements for Asparagus cochinchinensis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Asparagus cochinchinensis (Lour.) Merr.

14Constituent measurements

0Safety records

9Cited sources

181Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 181 licensed products naming Asparagus cochinchinensis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

Dried root(s)
New material
Root
Root extract
Root tuber(s)
Tuber

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Carboline alkaloids	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Dioscin	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Indole alkaloids	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Lignans	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Methylprotodioscin	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Pregnane derivatives	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Protodioscin	Roots and other underground parts used as staple food	Solvent extraction	0.5 Milligram/gram	LC-MS/MS	Resolve DOI
Saponins	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Steroidal furostan saponins	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Steroidal furostan saponins	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Steroidal spirostane saponins	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Lignans	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Methylprotodioscin	Roots and other underground parts	Solvent extraction	≥ 12.5 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Methylprotodioscin	Roots and other underground parts	Solvent extraction	≤ 30 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Zhang, HJ., Sydara, K., Tan, GT., Ma, CY., Southavong, B., Soejarto, DD., Pezzuto, JM., Fong, HHS. Bioactive constituents from Asparagus cochinchinensis. JOURNAL OF NATURAL PRODUCTS, 2004, vol. 67, no. 2, p. 194-200. DOI
Lee, Ju Hee., Lim, Hun Jai., Lee, Chan Woo., Kim, Hyun Pyo., Son, Kun-Ho., Son, Jong-Keun., Lee, Sang Kook. Methyl Protodioscin from the Roots of Asparagus cochinchinensis Attenuates Airway Inflammation by Inhibiting Cytokine Production. Evidence-based complementary and alternative medicine : eCAM, 2015, vol. 2015, p. 640846-None.
Jian, Rui., Zeng, Ke-Wu., Li, Jun., Li, Ning., Jiang, Yong., Tu, Pengfei. Anti-neuroinflammatory constituents from Asparagus cochinchinensis. Fitoterapia, 2013, vol. 84, p. 80-84. DOI
Jaiswal, Yogini., Liang, Zhitao., Ho, Alan., Chen, Hubiao., Zhao, Zhongzhen. A Comparative Tissue-specific Metabolite Analysis and Determination of Protodioscin Content in Asparagus Species used in Traditional Chinese Medicine and Ayurveda by use of Laser Microdissection, UHPLC-QTOF/MS and LC-MS/MS. PHYTOCHEMICAL ANALYSIS, 2014, vol. 25, no. 6, p. 514-528. DOI
Zhu Guo-Lei., Hao Qian., Li Rong-Tao., Li Hai-Zhou. Steroidal saponins from the roots of Asparagus cochinchinensis. CHINESE JOURNAL OF NATURAL MEDICINES, 2014, vol. 12, no. 3, p. 213-217. DOI
Shen, Yang., Xu, Cong-Li., Xuan, Wei-Dong., Li, Hui-Liang., Liu, Run-Hui., Xu, Xi-Ke., Chen, Hai-Sheng. A New Furostanol Saponin from Asparagus cochinchinensis. ARCHIVES OF PHARMACAL RESEARCH, 2011, vol. 34, no. 10, p. 1587-1591. DOI
Li, Xing-Nuo., Chu, Chu., Cheng, Dong-Ping., Tong, Sheng-Qiang., Yan, Ji-Zhong. Two Alkaloids from Asparagus cochinchinensis. CHEMISTRY OF NATURAL COMPOUNDS, 2014, vol. 50, no. 2, p. 326-328. DOI
Lee, Hyun Jae., Park, Jin Sung., Yoon, Yong Pill., Shin, Ye Jin., Lee, Sang Kook., Kim, Yeong Shik., Hong, Jang-Hee., Son, Kun Ho., Lee, Choong Jae. Dioscin and methylprotodioscin isolated from the root of Asparagus cochinchinensis suppressed the gene expression and production of airway MUC5AC mucin induced by phorbol ester and growth factor. PHYTOMEDICINE, 2015, vol. 22, no. 5, p. 568-572. DOI
Yang, Yan-yan., Wang, Zhe-xing. Isolation and identification of chemical constituents from the rhizome of Asparagus cochinchinensis.. Shenyang yaoke daxue xuebao, 2009, vol. 26, no. 10, p. 796-799.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature